621 related articles for article (PubMed ID: 22019006)
1. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
4. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
5. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.
Pergolizzi JV; Labhsetwar SA; Puenpatom RA; Joo S; Ben-Joseph R; Summers KH
Pain Pract; 2011; 11(4):325-36. PubMed ID: 21199317
[TBL] [Abstract][Full Text] [Related]
6. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
[TBL] [Abstract][Full Text] [Related]
7. [Drug-drug interactions in multicentre polypathological polymedicated patients].
Galindo-Ocaña J; Gil-Navarro MV; García-Morillo JS; Bernabeu-Wittel M; Ollero-Baturone M; Ortiz-Camuñez MA
Rev Clin Esp; 2010 Jun; 210(6):270-8. PubMed ID: 20434722
[TBL] [Abstract][Full Text] [Related]
8. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis.
Cannon KT; Choi MM; Zuniga MA
Am J Geriatr Pharmacother; 2006 Jun; 4(2):134-43. PubMed ID: 16860260
[TBL] [Abstract][Full Text] [Related]
10. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
11. Drug-drug interactions in a cohort of hospitalized elderly patients.
Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
[TBL] [Abstract][Full Text] [Related]
12. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a pharmacist medication review clinic for haemodialysis patients.
Mirkov S
N Z Med J; 2009 Jun; 122(1297):25-37. PubMed ID: 19648999
[TBL] [Abstract][Full Text] [Related]
14. Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients.
Cornu P; Steurbaut S; Leysen T; De Baere E; Ligneel C; Mets T; Dupont AG
Ann Pharmacother; 2012 Apr; 46(4):484-94. PubMed ID: 22414793
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of potential drug-drug interactions in opioid analgesics.
Summers KH; Puenpatom RA; Rajan N; Ben-Joseph R; Ohsfeldt R
J Med Econ; 2011; 14(4):390-6. PubMed ID: 21574905
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the impact of drug-drug interactions associated with opioids.
Pergolizzi JV
Am J Manag Care; 2011 Sep; 17 Suppl 11():S288-92. PubMed ID: 21999761
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
19. Do emergency physicians attribute drug-related emergency department visits to medication-related problems?
Hohl CM; Zed PJ; Brubacher JR; Abu-Laban RB; Loewen PS; Purssell RA
Ann Emerg Med; 2010 Jun; 55(6):493-502.e4. PubMed ID: 20005010
[TBL] [Abstract][Full Text] [Related]
20. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
